jacs-scope-fit

Scope and Venue Fit (jacs-scope-fit)

When to trigger

• You are unsure JACS is the right home versus a subfield ACS journal
• A co-author says "this is JACS-level" and you want a sober test
• An editor desk-rejected a prior version for "insufficient general interest"
• You must choose Article vs Communication early

The JACS bar (broad interest + rigor)

JACS publishes a **significant chemical advance of broad interest across

chemistry**, fully supported by data. Two tests must both pass:

1. Advance test — Is the result genuinely new and important, not incremental?

A new reaction/bond construction, a new mechanism or principle, a new

material/property, a new method that others will adopt, or a problem long

considered hard that you solved.

1. Breadth test — Will chemists outside your immediate subfield care?

Generality (scope), conceptual insight, or enabling utility are the usual

sources of breadth.

If only the advance test passes but breadth is narrow, a specialized journal is

the honest fit.

Venue decision table

| Situation | Likely better venue |

|-----------|---------------------|

| Broad, general-interest advance, fully supported | JACS (Article or Communication) |

| Solid methodology, mainly of interest within organic synthesis | Org. Lett. / J. Org. Chem. |

| Coordination/main-group/bioinorganic, subfield interest | Inorg. Chem. |

| Catalysis-focused, mechanism within catalysis community | ACS Catal. |

| Materials synthesis/properties, materials audience | Chem. Mater. / ACS Nano |

| Physical-chemistry measurement, PC audience | J. Phys. Chem. family |

| Incremental scope extension of a known reaction | Specialized journal, not JACS |

> Verify current sister-journal scopes on the ACS site; portfolios evolve.

Format fit (set expectations early)

• Communication — a complete, urgent, high-impact advance that can stand on

concise evidence (full proof lives in the SI). Choose when timeliness and a

clean central result dominate.

• Article — a full account with complete scope, controls, and mechanism.

Choose when the story needs tables of scope, multiple mechanistic probes, or

several characterized systems.

• Confirm current article types and limits on the JACS author page; hand sizing

to jacs-length-management.

Naming the breadth driver (be specific)

Editors triage on whether the manuscript itself argues breadth. Pick one primary

driver and make the abstract carry it:

| Breadth driver | What must be in the data | Example framing |

|----------------|--------------------------|-----------------|

| Generality | Scope spanning substrate classes others use daily; failures disclosed | "…across ethers, amines, and three drug scaffolds" |

| Concept / mechanism | A principle transferable beyond the system (new elementary step, selectivity model) | "…establishes ligand-controlled distal selectivity as a design rule" |

| Enabling utility | Something practitioners can now do (a disconnection, a probe, a material function) | "…renders the C(sp³)–F disconnection strategic in route design" |

| Long-standing problem | Documented prior failures by others; your data closing the gap | "…solves the site-selectivity problem posed since [prior art]" |

If you cannot fill the middle column from your own data, the driver is aspirational

— either gather the missing evidence or pivot venue now, before writing.

Worked micro-example (same chemistry, two pitches)

• **Subfield pitch (belongs at Org. Lett.):** "We extend Ni-catalyzed

hydroamination to six new pyrazole nucleophiles in 61–88% yield."

• JACS pitch (only if the data back it): "A single Ni catalyst couples any

N–H heterocycle class we tested (5 azole families, 31 examples) with

unactivated olefins, and kinetics reveal why: turnover-limiting olefin

insertion is insensitive to azole pKa — a generality mechanism, not a scope

accident."

The second pitch is honest only when the kinetics and the five-family scope

exist. The scope-fit call is therefore a data audit, not a wording exercise.

Desk-rejection signals worth heeding

• Your own abstract needs a subfield term (e.g., a niche ligand class) to state

why the result matters — the breadth case has not been made.

• The closest peer papers you can cite are all in specialized journals, none in

JACS from the past few volumes.

• The advance sentence begins "We extend / We also / We further" — extension

language reads as incremental at a flagship venue.

Checklist

• [ ] One sentence states the advance in terms a non-specialist chemist grasps
• [ ] The breadth source is named (generality / concept / enabling utility)
• [ ] At least two recent JACS papers in adjacent areas are identified as peers
• [ ] An honest answer to "why not a specialized journal?" is written down
• [ ] The intended format (Article vs Communication) is chosen with a reason
• [ ] No claim of breadth that the data cannot support

Anti-patterns

• Equating "lots of work" with "broad interest" — effort is not significance
• "First example of X in our hands" framed as a field-wide first
• Pitching an incremental substrate-scope paper as a conceptual advance
• Choosing Communication when the central claim actually needs full Article-level support

Output format

【Advance】one-sentence statement of the new chemistry
【Breadth source】generality / concept / enabling utility
【Verdict】JACS-fit / better at <named ACS journal>
【Format】Article / Communication (+ reason)
【Next】jacs-results-framing (if JACS-fit) or pivot venue

Related resources

• [../../resources/external_tools.md](../../resources/external_tools.md) — characterization platforms and deposition services